Judge Balks At ViroPharma's Bid To Halt Vancocin Generics
By Erica Teichert ( April 19, 2012, 8:52 PM EDT) -- ViroPharma Inc.'s bid to halt the U.S. Food and Drug Administration's recent approval of three generic versions of its gastrointestinal antibiotic Vancocin hit a possible snag Thursday when a Washington federal judge said even a temporary hold on the agency's decision also could cause significant harm to the generics makers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.